Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

CB

Chubb Limited

May 03 • 04:00PM ET

248.54

Dollar change -1.71
Percentage change -0.68	%

Financial • Insurance - Property & Casualty • Switzerland • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO IVV VTV VIG VYM USMV IWD RDVY JEPI

Index	S&P 500	P/E	11.03	EPS (ttm)	22.53	Insider Own	0.60%	Shs Outstand	405.27M	Perf Week	1.26%
Market Cap	100.92B	Forward P/E	10.49	EPS next Y	23.69	Insider Trans	-7.58%	Shs Float	403.62M	Perf Month	-1.46%
Income	9.28B	PEG	0.62	EPS next Q	5.39	Inst Own	86.36%	Short Float	0.64%	Perf Quarter	0.75%
Sales	51.73B	P/S	1.95	EPS this Y	-3.85%	Inst Trans	-0.57%	Short Ratio	1.58	Perf Half Y	12.81%
Book/sh	149.09	P/B	1.67	EPS next Y	9.31%	ROA	4.73%	Short Interest	2.60M	Perf Year	25.66%
Cash/sh	-	P/C	-	EPS next 5Y	17.70%	ROE	16.35%	52W Range	183.71 - 260.58	Perf YTD	9.97%
Dividend Est.	3.60 (1.45%)	P/FCF	6.88	EPS past 5Y	20.76%	ROI	12.39%	52W High	-4.62%	Beta	0.65
Dividend TTM	3.44 (1.38%)	Quick Ratio	-	Sales past 5Y	8.99%	Gross Margin	-	52W Low	35.29%	ATR (14)	3.84
Dividend Ex-Date	Mar 14, 2024	Current Ratio	0.44	EPS Y/Y TTM	80.70%	Oper. Margin	19.12%	RSI (14)	48.56	Volatility	1.37% 1.45%
Employees	40000	Debt/Eq	0.32	Sales Y/Y TTM	15.73%	Profit Margin	17.94%	Recom	2.07	Target Price	270.05
Option/Short	Yes / Yes	LT Debt/Eq	0.24	EPS Q/Q	15.53%	Payout	15.65%	Rel Volume	0.88	Prev Close	250.25
Sales Surprise	3.97%	EPS Surprise	1.84%	Sales Q/Q	15.57%	Earnings	Apr 23 AMC	Avg Volume	1.64M	Price	248.54
SMA20	0.32%	SMA50	-1.38%	SMA200	9.52%	Trades		Volume	1,444,701	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-04-24	Downgrade	HSBC Securities	Buy → Hold	$275 → $270
Mar-14-24	Downgrade	Citigroup	Buy → Neutral	$238 → $275
Jan-10-24	Initiated	TD Cowen	Market Perform	$254
Jan-08-24	Downgrade	Goldman	Buy → Neutral	$222
Dec-28-23	Initiated	HSBC Securities	Buy	$263
Dec-18-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$253 → $240
Oct-05-23	Initiated	Deutsche Bank	Buy	$269
Oct-02-23	Downgrade	JP Morgan	Overweight → Neutral	$250
Jun-20-23	Initiated	Morgan Stanley	Equal-Weight	$192
Apr-18-23	Upgrade	Citigroup	Neutral → Buy	$229
Mar-17-23	Upgrade	JP Morgan	Neutral → Overweight	$239
Jan-20-23	Initiated	BMO Capital Markets	Market Perform	$225
Jan-09-23	Downgrade	Jefferies	Buy → Hold	$246
Dec-05-22	Reiterated	MKM Partners	Buy	$235 → $260
Nov-15-22	Upgrade	Atlantic Equities	Neutral → Overweight	$240
May-24-22	Initiated	Citigroup	Neutral	$209
Nov-23-21	Initiated	Goldman	Buy	$230
Nov-19-21	Initiated	Jefferies	Buy	$235
Oct-15-21	Resumed	Morgan Stanley	Equal-Weight	$200
Aug-17-21	Initiated	Wolfe Research	Outperform	$231

Show Previous Ratings

May-04-24 10:53AM	APi Group Corporation (NYSE:APG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 08:23AM	The insurer for the collapsed Baltimore bridge will pay out $350 million (Quartz)
07:22AM	UPDATE 2-Insurer Chubb readies $350 mln payout tied to Baltimore bridge collapse (Reuters)
06:27AM	Insurer Chubb readies $350 million payout tied to Baltimore bridge collapse (Reuters)
06:23AM	Market Chatter: Chubb to Compensate Maryland $350 Million for Baltimore Bridge Disaster Within Weeks (MT Newswires)
05:30AM	Loading…
05:30AM	Insurer to Make $350 Million Payout in Baltimore Bridge Collapse (The Wall Street Journal)
Apr-29-24 05:22PM	17 Best Insurance Dividend Stocks To Invest In Right Now (Insider Monkey)
Apr-28-24 06:49PM	What is an Annuity for Retirement? 15 Dividend Stocks to Buy Instead (Insider Monkey)
Apr-27-24 01:07AM	Decoding Chubb Ltd (CB): A Strategic SWOT Insight (GuruFocus.com)
Apr-25-24 11:17AM	Chubb Limited (NYSE:CB) Q1 2024 Earnings Call Transcript (Insider Monkey)
04:57AM	Chubb Report: Damage During Home Renovations and from Extreme Weather are Top Concerns of U.K. High Earners (PR Newswire)
Apr-24-24 03:33PM	Why Chubb Limited Fell Today (Motley Fool)
02:16PM	Chubb's (CB) Q1 Earnings Top Estimates, Premiums Rise Y/Y (Zacks)
11:34AM	Analyst Report: Chubb Limited (Morningstar Research)
Apr-23-24 08:53PM	CB Stock Earnings: Chubb Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:00PM	Loading…
07:00PM	Chubb (CB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:52PM	Chubb Ltd (CB) Q1 Earnings: Solid Performance with Core Operating Income and Premiums Exceeding ... (GuruFocus.com)
05:49PM	Insurer Chubb's Q1 profit rises on strong investment returns, underwriting (Reuters)
05:35PM	Chubb (CB) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:42PM	Chubb Q1 Core Operating Income, Net Premiums Increase (MT Newswires)
04:33PM	Chubb: Q1 Earnings Snapshot (Associated Press Finance)
04:20PM	Chubb Reports First Quarter Per Share Net Income and Core Operating Income of $5.23 and $5.41, Up 15.5% and 22.7%, Respectively; Consolidated Net Premiums Written of $12.2 Billion, Up 14.1%, with P&C Up 12.4% and Life Insurance Up 26.3%; P&C Combined Ratio of 86.0% (PR Newswire)
Apr-22-24 05:00AM	Chubb to Acquire Healthy Paws, a Leading Pet Insurance Provider (PR Newswire)
Apr-19-24 06:44AM	Chubb Limited (CB) to Report Q1 Earnings: What's in Store? (Zacks)
Apr-18-24 09:15AM	Countdown to Chubb (CB) Q1 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Apr-16-24 10:00AM	Chubb (CB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-15-24 01:00PM	Combined Insurance Continues Legacy of Military Support (PR Newswire)
07:43AM	16 Best Dividend Stocks of All Time (Insider Monkey)
Apr-11-24 01:43PM	Final Trades: Toast, Chevron, Chubb and GSG (CNBC TV)
Apr-04-24 05:10PM	15 Fastest Sinking Cities in the World (Insider Monkey)
03:45AM	Loading…
Apr-02-24 03:45AM	Could This Undervalued Stock Make You a Millionaire One Day? (Motley Fool)
Apr-01-24 07:01PM	Oxford Industries, Inc. (NYSE:OXM) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-31-24 08:18AM	Insiders Are Dumping These 5 Financial Stocks (Insider Monkey)
Mar-28-24 07:30AM	Chubb Limited to Hold its First Quarter Earnings Conference Call on Wednesday, April 24, 2024 (PR Newswire)
Mar-27-24 12:00PM	Chubb Limited (CB) Upgraded to Buy: Here's What You Should Know (Zacks)
09:00AM	Chubb Launches New Platform to Give Agents Quicker Access to Flood Quotes (PR Newswire)
05:30AM	Chubb Launches HealthTech Industry Practice in UK (PR Newswire)
02:20AM	Xi Meets US CEOs, Seeking to Boost Confidence in Chinas Economy (Bloomberg)
Mar-25-24 09:05PM	22 States with the Most Tornadoes in the US (Insider Monkey)
Mar-21-24 08:04PM	15 Best States for Homeowners Insurance in the US (Insider Monkey)
08:02PM	25 Largest Insurance Companies in the World in 2024 (Insider Monkey)
01:31PM	Chubb (CB) Shares Rise 21% in 6 months: Will the Bull Run Stay? (Zacks)
Mar-19-24 11:00AM	Executive Vice President Joseph Wayland Sells Shares of Chubb Ltd (CB) (GuruFocus.com)
08:49AM	30 Undervalued Dividend Aristocrats To Buy According to Analysts (Insider Monkey)
Mar-18-24 09:00AM	Chubb Launches Global Transactional Risk Platform to Grow its Footprint Internationally (PR Newswire)
Mar-15-24 07:45AM	Looking for Income? This Blue Chip Dividend Stock Just Raised Its Payout for the 30th Year in a Row (Motley Fool)
Mar-14-24 02:36PM	Calls of the Day: Caterpillar, IBM, RTX and Chubb (CNBC TV)
Mar-13-24 07:01AM	Chubb Ltd's Dividend Analysis (GuruFocus.com)
Mar-12-24 07:55PM	25 Most Earthquake-Prone Countries in the World (Insider Monkey)
Mar-11-24 02:22PM	Final Trades: Natera, Disney, Chubb and ASML Holding (CNBC TV)
Mar-08-24 09:40AM	Is Chubb Limited (CB) Outperforming Other Finance Stocks This Year? (Zacks)
Mar-05-24 04:17PM	13 Best Dividend Stocks For Rising Interest Rates (Insider Monkey)
Mar-04-24 08:45PM	Chubb Limited Announces Pricing of $1 Billion Senior Notes Offering by Subsidiary (PR Newswire)
Feb-29-24 11:30AM	Chubb (CB) Up 3.5% Since Last Earnings Report: Can It Continue? (Zacks)
Feb-28-24 04:09AM	20 Best Personal Injury Lawyers in NYC (Insider Monkey)
Feb-24-24 02:28PM	30 Cheapest Places To Visit In The World (Insider Monkey)
12:06AM	Decoding Chubb Ltd (CB): A Strategic SWOT Insight (GuruFocus.com)
Feb-23-24 02:13PM	Chubb (CB) to Propose 5.8% Dividend Hike to Share More Profit (Zacks)
06:39AM	30 Safest Countries In the World in 2024 (Insider Monkey)
Feb-22-24 08:16PM	Analyst Report: Chubb Limited (Morningstar Research)
11:19AM	Here's Why Chubb (CB) Shares Are Attracting Investors Now (Zacks)
10:00AM	2024 Outlook: Middle Market Companies Set Financial Growth Records, Yet Remain Cautiously Optimistic Amid Emerging Risks (PR Newswire)
09:15AM	Chubb Limited (CB) Hits Fresh High: Is There Still Room to Run? (Zacks)
06:30AM	Chubb Limited Board Will Recommend 31st Consecutive Annual Dividend Increase to Shareholders at the 2024 Annual General Meeting; Declares Quarterly Dividend (PR Newswire)
Feb-21-24 06:24PM	Survey: Consumers trust e-commerce, but have concerns (Chain Store Age)
08:00AM	E-Commerce Grows But Trust in Digital Channels is Uneven: Chubb Survey (PR Newswire)
Feb-17-24 05:24PM	15 Worst States for Homeowners Insurance in the US (Insider Monkey)
Feb-14-24 09:27AM	How Does Chubb Interaction Help APi Group (APG) for Further Growth? (Insider Monkey)
Feb-10-24 02:29AM	Best Workers Compensation Lawyers in Each of 30 Biggest Cities in the US (Insider Monkey)
Feb-06-24 09:15AM	Chubb Limited (CB) Hits Fresh High: Is There Still Room to Run? (Zacks)
Feb-05-24 04:03PM	10 Best Cheap Car Insurance in New York for 2024 (Insider Monkey)
Feb-02-24 11:01AM	Chubb Ltd Chief Accounting Officer Annmarie Hagan Sells 7,180 Shares (GuruFocus.com)
Feb-01-24 11:27AM	Chubb Limited (NYSE:CB) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-31-24 12:45PM	Chubb Appoints Seth Gillston Head of North America Industry Practices (PR Newswire)
11:53AM	Analyst Report: Chubb Limited (Morningstar Research)
10:50AM	14 Best Consistent Dividend Stocks To Invest In (Insider Monkey)
09:05AM	Chubb (CB) Q4 Earnings Beat Estimates on Underwriting Strength (Zacks)
06:45AM	Chubb Ltd (CB) Reports Record Earnings, Strong Premium Growth in Q4 and Full-Year 2023 (GuruFocus.com)
Jan-30-24 09:30PM	Chubb (CB) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:15PM	Chubb (CB) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:41PM	Insurer Chubb's Q4 profit surges on stronger underwriting, investment returns (Reuters)
05:24PM	Chubb: Q4 Earnings Snapshot (Associated Press Finance)
05:00PM	Chubb Reports Record Fourth Quarter Per Share Net Income and Core Operating Income of $8.03 and $8.30, Up 156.5% and 107.5%, Respectively; Consolidated Net Premiums Written of $11.6 Billion, Up 13.4%, with P&C Up 12.5%; P&C Combined Ratio of 85.5%; Record Full-Year Per Share Net Income and Core Operating Income of $21.80 and $22.54, Up 75.9% and 48.5%, Respectively; Consolidated Net Premiums Written of $47.4 Billion, Up 13.5%, with P&C Up 9.9%; Record P&C Combined Ratio of 86.5% (PR Newswire)
06:13AM	13 Cheapest Dividend Aristocrats Right Now (Insider Monkey)
Jan-29-24 08:34AM	Should You Buy Chubb (CB) Ahead of Earnings? (Zacks)
Jan-26-24 08:11AM	Is a Beat in Store for Chubb Limited (CB) in Q4 Earnings? (Zacks)
Jan-25-24 09:15AM	Ahead of Chubb (CB) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Jan-23-24 07:49PM	20 Safest Countries for US Travelers in the World (Insider Monkey)
10:00AM	Chubb (CB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:30AM	StreamLabs Expands Product Suite with Scout, a New Smart Water Sensor (PR Newswire)
Jan-22-24 11:45AM	Chubb Stock Sees Composite Rating Climb To 96 Ahead Of Earnings (Investor's Business Daily)
Jan-19-24 09:50AM	Here's Why Chubb (CB) is a Strong Momentum Stock (Zacks)
Jan-16-24 03:15PM	15 States with the Cheapest Home Insurance in the US (Insider Monkey)
Jan-11-24 12:10PM	Will Chubb (CB) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-10-24 09:40AM	Chubb (CB) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jan-05-24 01:00PM	Chubb Limited to Hold its Fourth Quarter Earnings Conference Call on Wednesday, January 31, 2024 (PR Newswire)
Dec-30-23 03:30AM	13 Biggest Stocks That Benefit From High Interest Rates (Insider Monkey)
Dec-29-23 08:58AM	These 2 Insurance Stocks Hit 52-Week High and Are Still a Buy, Says Analyst (TipRanks)
Dec-28-23 06:38PM	15 Best Home Insurance Companies Heading into 2024 (Insider Monkey)
Dec-22-23 03:22PM	15 Best Group Insurance Companies Heading into 2024 (Insider Monkey)

Chubb Ltd. operates as a holding company, which engages in the provision of commercial and personal property and casualty insurance, personal accident and accident and health (A&H), reinsurance, and life insurance. It operates through the following segments: North America Commercial Property and Casualty (P&C) Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. The North America Commercial P&C Insurance segment that includes the business written by Chubb divisions that provide P&C insurance and services to large, middle market and small commercial businesses in the U.S., Canada, and Bermuda. The North America Personal P&C Insurance segment offers affluent and high net worth individuals and families with homeowners, high value automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The North America Agricultural Insurance segment is involved in comprehensive multiple peril crop insurance (MPCI) and crop-hail insurance, and Chubb agribusiness. The Overseas General Insurance segment caters for both commercial and consumer P&C insurance and services in countries and territories outside of North America where the company operates. The Global Reinsurance segment covers reinsurance business. The Life Insurance segment focuses on its international life operations. The company was founded in 1882 and is headquartered in Zurich, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOROUGHS TIMOTHY ALAN	Executive Vice President*	Mar 20 '24	Sale	258.78	14,303	3,701,344	35,662	Mar 22 01:30 PM
BOROUGHS TIMOTHY ALAN	Executive Vice President*	Mar 20 '24	Sale	259.05	5,697	1,475,817	0	Mar 22 01:30 PM
Lupica John J	Vice Chrm, Chubb Group*	Mar 19 '24	Option Exercise	114.78	25,479	2,924,480	165,401	Mar 21 05:30 PM
Lupica John J	Vice Chrm, Chubb Group*	Mar 19 '24	Sale	258.92	34,464	8,923,566	130,937	Mar 21 05:30 PM
Wayland Joseph F	Executive Vice President and*	Mar 15 '24	Option Exercise	116.67	27,424	3,199,559	110,481	Mar 19 08:11 AM
Wayland Joseph F	Executive Vice President and*	Mar 15 '24	Sale	257.02	26,946	6,925,777	95,252	Mar 19 08:11 AM
BOROUGHS TIMOTHY ALAN	Executive Vice President*	Feb 26 '24	Option Exercise	116.64	33,150	3,866,453	67,521	Feb 28 05:48 PM
BOROUGHS TIMOTHY ALAN	Executive Vice President*	Feb 26 '24	Sale	255.11	33,150	8,456,758	50,486	Feb 28 05:48 PM
GREENBERG EVAN G	Chairman & CEO	Feb 06 '24	Sale	248.37	58,730	14,586,770	609,618	Feb 06 06:54 PM
GREENBERG EVAN G	Chairman & CEO	Feb 02 '24	Option Exercise	96.76	1,033	99,953	668,348	Feb 06 06:54 PM
HAGAN ANNMARIE T	Chief Accounting Officer	Feb 01 '24	Sale	245.04	7,180	1,759,387	6,105	Feb 02 09:28 AM
Ortega Juan Luis	Executive Vice President*	Nov 08 '23	Option Exercise	96.76	1,508	145,914	51,448	Nov 09 02:33 PM
Ortega Juan Luis	Executive Vice President*	Nov 08 '23	Sale	218.63	1,508	329,694	49,940	Nov 09 02:33 PM
Lupica John J	Vice Chrm, Chubb Group*	Nov 06 '23	Sale	218.76	17,810	3,896,155	136,239	Nov 08 07:43 AM
Wayland Joseph F	Executive Vice President and*	Sep 19 '23	Option Exercise	96.76	6,890	666,676	104,852	Sep 21 08:53 AM
Wayland Joseph F	Executive Vice President and*	Sep 19 '23	Sale	213.67	11,537	2,465,101	93,315	Sep 21 08:53 AM
Keogh John W	President & COO	Aug 24 '23	Option Exercise	96.76	1,033	99,953	275,767	Aug 28 01:03 PM
Keogh John W	President & COO	Aug 24 '23	Sale	201.01	10,000	2,010,100	265,184	Aug 28 01:03 PM
Shasta Theodore	Director	Aug 14 '23	Sale	201.94	699	141,156	14,511	Aug 16 08:27 AM
BOROUGHS TIMOTHY ALAN	Executive Vice President*	Aug 01 '23	Sale	205.41	1,500	308,115	2,335	Aug 03 04:56 PM
ATIEH MICHAEL G	Director	Jul 28 '23	Sale	208.39	750	156,292	38,933	Aug 14 12:18 PM
HAGAN ANNMARIE T	Chief Accounting Officer	Jul 27 '23	Option Exercise	118.39	2,028	240,095	14,421	Jul 31 10:51 AM
Lupica John J	Vice Chrm, Chubb Group*	Jul 27 '23	Sale	211.74	8,398	1,778,193	154,049	Jul 31 10:54 AM
HAGAN ANNMARIE T	Chief Accounting Officer	Jul 27 '23	Sale	211.81	1,187	251,418	13,234	Jul 31 10:51 AM

Open in Screener

BHVN

Biohaven Ltd

May 03 • 04:00PM ET

40.69

Dollar change +0.79
Percentage change 1.98	%

Healthcare • Biotechnology • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IWM VBR VXF IWN IBB VTWO SCHA VHT

Index	RUT	P/E	-	EPS (ttm)	-5.67	Insider Own	14.67%	Shs Outstand	81.12M	Perf Week	4.41%
Market Cap	3.56B	Forward P/E	-	EPS next Y	-5.81	Insider Trans	3.06%	Shs Float	74.59M	Perf Month	-22.24%
Income	-408.17M	PEG	-	EPS next Q	-1.55	Inst Own	82.97%	Short Float	11.95%	Perf Quarter	-9.15%
Sales	0.00M	P/S	-	EPS this Y	-9.97%	Inst Trans	334.79%	Short Ratio	6.65	Perf Half Y	37.98%
Book/sh	5.28	P/B	7.71	EPS next Y	7.72%	ROA	-69.48%	Short Interest	8.91M	Perf Year	195.93%
Cash/sh	4.38	P/C	9.28	EPS next 5Y	-	ROE	-84.44%	52W Range	13.03 - 62.21	Perf YTD	-4.93%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-89.60%	52W High	-34.59%	Beta	4.52
Dividend TTM	-	Quick Ratio	7.98	Sales past 5Y	0.00%	Gross Margin	-	52W Low	212.28%	ATR (14)	2.75
Dividend Ex-Date	-	Current Ratio	7.98	EPS Y/Y TTM	33.62%	Oper. Margin	0.00%	RSI (14)	38.17	Volatility	5.24% 6.34%
Employees	239	Debt/Eq	0.07	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.09	Target Price	59.33
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	38.59%	Payout	-	Rel Volume	0.59	Prev Close	39.90
Sales Surprise	-	EPS Surprise	-28.25%	Sales Q/Q	-	Earnings	Feb 29 AMC	Avg Volume	1.34M	Price	40.69
SMA20	-7.54%	SMA50	-18.80%	SMA200	14.45%	Trades		Volume	784,680	Change	1.98%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-16-24	Initiated	RBC Capital Mkts	Outperform	$62
Feb-06-24	Initiated	UBS	Buy	$59
Dec-22-23	Initiated	H.C. Wainwright	Buy	$50
Dec-08-23	Initiated	Robert W. Baird	Outperform	$58
Jan-24-23	Initiated	SVB Securities	Outperform	$24
Jan-04-23	Initiated	JP Morgan	Overweight	$23
Dec-02-22	Initiated	BTIG Research	Buy	$24
Oct-26-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$158 → $27
Oct-12-22	Initiated	Piper Sandler	Overweight	$23
Aug-19-22	Downgrade	Piper Sandler	Overweight → Neutral	$149
Aug-08-22	Downgrade	Wedbush	Outperform → Neutral	$148.50
May-11-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$150
Oct-19-21	Resumed	Morgan Stanley	Equal-Weight	$107 → $145
Aug-10-21	Downgrade	UBS	Buy → Neutral	$108 → $109
Aug-03-21	Reiterated	Canaccord Genuity	Buy	$101 → $150
Mar-11-21	Initiated	UBS	Buy	$108
Dec-15-20	Initiated	H.C. Wainwright	Buy	$121
Apr-17-20	Initiated	Cowen	Outperform	$45
Feb-10-20	Downgrade	Oppenheimer	Outperform → Perform
Feb-06-20	Initiated	Mizuho	Buy

Show Previous Ratings

May-01-24 02:38PM	Shhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radar (InvestorPlace)
Apr-26-24 06:00AM	3 Biotech Stocks to Buy on the Dip: April 2024 (InvestorPlace)
Apr-25-24 11:00AM	Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Apr-23-24 11:00AM	Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Apr-22-24 04:05PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
06:00AM	Loading…
Apr-18-24 06:00AM	Biohaven Announces Pricing of $230 Million Public Offering of Common Shares (PR Newswire)
Apr-17-24 04:05PM	Biohaven Announces Proposed Public Offering of Common Shares (PR Newswire)
Apr-13-24 09:00AM	Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates (PR Newswire)
Apr-03-24 10:03PM	LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside? (TipRanks)
Feb-29-24 04:05PM	Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments (PR Newswire)
Jan-25-24 05:31PM	Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs (InvestorPlace)
Jan-22-24 07:00AM	Obesity Drugs Lead to Muscle LossPharma Companies Want to Fix That (The Wall Street Journal) +9.24%
Jan-08-24 07:30AM	Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology (PR Newswire) +10.50%
Jan-02-24 07:00AM	Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-23 03:01AM	Director Irina Antonijevic Sells 11,000 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
04:30PM	Loading…
Dec-01-23 04:30PM	Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting (PR Newswire)
Nov-16-23 09:40AM	Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year? (Zacks)
Nov-14-23 09:15PM	Biohaven Ltd (BHVN) Reports Q3 2023 Financial Results: Advances in Clinical Programs and Strong ... (GuruFocus.com)
04:05PM	Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments (PR Newswire)
Nov-06-23 08:50AM	Biohaven Ltd. (BHVN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) -6.39%
Oct-31-23 09:40AM	Are Medical Stocks Lagging Biohaven Ltd. (BHVN) This Year? (Zacks)
Oct-19-23 08:50AM	Here's Why Momentum in Biohaven Ltd. (BHVN) Should Keep going (Zacks)
Oct-16-23 07:00AM	Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek (PR Newswire)
Oct-06-23 01:01PM	Insider Buying: CFO Matthew Buten Acquires 22,727 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Oct-05-23 04:05PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire) +5.32%
Oct-03-23 08:50AM	Here's What Could Help Biohaven Ltd. (BHVN) Maintain Its Recent Price Strength (Zacks)
Oct-02-23 11:56PM	Biohaven Announces Pricing of $225 Million Public Offering of Common Shares (PR Newswire) -7.46%
04:36PM	BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES (PR Newswire)
Sep-29-23 10:00AM	Small Biotech Stocks Haven't Shined of Late, but I Think These 3 Could Be Stars (TheStreet.com)
10:00AM	3 Small Biotech Stocks That Could Be Stars (TheStreet.com)
07:53AM	Loading…
Sep-28-23 07:53AM	Biohaven (BHVN) Up on Positive Data from Autoimmune Disease Drug (Zacks) +10.54%
Sep-27-23 04:09PM	Biohaven, Yet Another Rival To Argenx In Autoimmune Drugs, Just Rocketed 33% (Investor's Business Daily) +33.31%
12:25PM	Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29% (Investor's Business Daily)
12:00PM	Why Biohaven Stock Is Skyrocketing Today (Motley Fool)
Sep-14-23 07:00AM	Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy (PR Newswire)
Sep-05-23 07:00AM	Biohaven Announces Positive Data from its Exploratory Electroencephalogram (EEG) Biomarker Study of BHV-7000, Completion of Once-Daily Formulation Development, and Plan to Initiate Phase 3 Pivotal Studies (PR Newswire) -6.18%
Aug-09-23 06:01AM	Independent Director of Biohaven Picks Up 1.8% More Stock (Simply Wall St.)
Jul-31-23 09:31AM	Biohaven's Taldefgrobep Alfa Receives EU Orphan Drug Designation for Spinal Muscular Atrophy (PR Newswire)
06:59AM	Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments (PR Newswire)
Jul-27-23 12:50PM	Why Biohaven Stock Is Crashing Today (Motley Fool) -22.61%
07:00AM	Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates (PR Newswire)
Jun-27-23 05:31AM	2 Growth Stocks With Major Incoming Catalysts (Motley Fool)
Jun-02-23 09:11AM	Why Biohaven Stock Caught Fire This Week (Motley Fool)
Jun-01-23 04:08PM	Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High (Investor's Business Daily) +18.39%
01:01PM	How Biohaven Is Coming 'Out Of Stealth Mode' And Bullishly Extending A 4-Day Run (Investor's Business Daily)
11:29AM	Biohaven (BHVN) Stock up 8% on Encouraging Pipeline Updates (Zacks)
May-31-23 07:00AM	Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day (PR Newswire) +7.56%
May-25-23 05:00PM	Biohaven to Present R&D Day at Yale School of Management (PR Newswire)
May-24-23 01:30PM	These Small-Cap Biotech Stocks Have the Wind at Their Back (TheStreet.com) -5.34%
May-12-23 04:30PM	Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments (PR Newswire)
May-05-23 10:43AM	Is Biohaven (NYSE:BHVN) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Apr-17-23 07:00AM	Biohaven Expands Executive Leadership Team with Appointment of Nick Kozauer M.D. as Senior Vice President for Clinical Development and Regulatory Strategy (PR Newswire) +9.01%
Mar-30-23 09:40AM	Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-25-23 09:22AM	Bullish Biohaven Ltd. (NYSE:BHVN) insiders filled their treasuries with US$37m worth of stock over last year (Simply Wall St.)
Mar-23-23 04:05PM	Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments (PR Newswire)
11:09AM	Biohaven (BHVN) Acquires Dual Inhibitor for Brain Disorders (Zacks)
Mar-22-23 07:30AM	Biohaven Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders (PR Newswire) -5.89%
Mar-14-23 07:30AM	Biohaven Announces Presentation at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting (PR Newswire)
Mar-13-23 11:39AM	Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret (Zacks) +7.48%
Feb-23-23 08:36AM	Why Earnings Season Could Be Great for Biohaven (BHVN) (Zacks)
Feb-21-23 07:30AM	Biohaven's Taldefgrobep Alfa Receives FDA Fast Track Designation for Spinal Muscular Atrophy (PR Newswire) -7.69%
Feb-10-23 02:55PM	JPMorgans Best Performing 15 Stock Picks for 2023 (Insider Monkey)
Feb-02-23 12:52PM	Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric (Investor's Business Daily)
Jan-06-23 07:58AM	J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher This Is What Makes Them Attractive Buys (TipRanks)
07:30AM	Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-05-23 09:40AM	Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year? (Zacks) -5.94%
Dec-23-22 06:21AM	Biohaven Ltd.'s (NYSE:BHVN) market cap dropped US$151m last week; individual investors who hold 55% were hit as were institutions (Simply Wall St.) +6.44%
Nov-29-22 09:35AM	After Plunging 13% in 4 Weeks, Here's Why the Trend Might Reverse for Biohaven Ltd. (BHVN) (Zacks) +6.87%
Nov-28-22 09:55AM	How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 54% (Zacks) -9.09%
Nov-21-22 09:33AM	George Soros Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks)
Nov-09-22 08:35AM	Biohaven Ltd. (BHVN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -5.33%
07:00AM	Biohaven Ltd. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments (PR Newswire)
Nov-08-22 11:52AM	George Soros Stock Portfolio: Top 10 Stock Picks (Insider Monkey)
Nov-06-22 11:48AM	3 Hot Insider Trades, Plus Hedge Fund Moves: Coca-Cola, Biohaven, Carl Icahn (Investing.com)
07:00AM	Call This an Off-Label Trade (TheStreet.com)
Nov-01-22 10:01AM	Biohaven Ltd. (BHVN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-25-22 08:21PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
04:30PM	Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University (PR Newswire)
Oct-20-22 10:30PM	Biohaven Announces Pricing of Public Offering of Common Shares (PR Newswire)
Oct-18-22 04:12PM	Biohaven Announces Launch of Public Offering of Common Shares (PR Newswire)
Oct-07-22 03:24AM	Biohaven Ltd. (BHVN) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Oct-06-22 10:54AM	Biohaven (BHVN) Stock Up on Spin-Off Transaction Finalization (Zacks) +7.59%
Oct-05-22 04:45PM	Why Biohaven Stock Skyrocketed Again Today (Motley Fool) +47.59%
Oct-04-22 12:29PM	Why Biohaven Stock Is Soaring Today (Motley Fool) +18.57%
07:30AM	Biohaven Sets New Course with $258 Million in Cash, a Proven Team and Deep Pipeline to Continue its Journey to Advance Science for Patients (PR Newswire)
Oct-03-22 01:01PM	Pfizer Completes Acquisition of Biohaven Pharmaceuticals (Business Wire) +11.11%
Sep-30-22 04:09PM	Highly Rated Amylyx Pharma Skids After Hard-Fought FDA Approval For ALS Drug (Investor's Business Daily) -6.80%
01:04PM	Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both Endpoints (Zacks)
Sep-29-22 04:09PM	Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test (Investor's Business Daily) -11.05%
12:24PM	Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months (Benzinga)
08:39AM	UPDATE 1-Biohaven's ALS drug fails to meet study goals (Reuters)
08:00AM	Biohaven Provides Update From Pivotal Phase 2/3 Trial with Verdiperstat in Amyotrophic Lateral Sclerosis (Healy ALS Platform Trial) (PR Newswire)
Sep-23-22 09:36AM	10 Best Blue Chip Stocks to Buy According to Phill Gross and Robert Atchinsons Adage Capital (Insider Monkey)
Sep-18-22 07:42PM	Biohaven Announces Record Date for Anticipated Spin-Off (PR Newswire)
Sep-07-22 11:30AM	Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 9.8% Since Last Earnings Report? (Zacks)
Aug-31-22 03:25PM	Hedge Funds Continue to Load Up on These 10 Growth Stocks Despite Recession Fears (Insider Monkey)
07:00AM	Real-World Administrative Claims Analysis Demonstrates That Almost Half of Migraine Patients Discontinue Barbiturate Use After Initiation of Nurtec ODT (PR Newswire)
Aug-30-22 06:20AM	Should iShares Morningstar SmallCap ETF (ISCB) Be on Your Investing Radar? (Zacks)
Aug-09-22 04:46PM	Get ready for more merger mania in the pharma sector for the rest of the year (MarketWatch)
Aug-08-22 12:39PM	Biohaven Pharmaceutical (BHVN) Q2 Earnings Lag, Sales Beat (Zacks)

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bailey Gregory	Director	Apr 24 '24	Buy	39.18	25,503	999,169	1,600,071	Apr 25 07:32 AM
CHILDS JOHN W	Director	Apr 22 '24	Buy	41.00	195,121	7,999,961	4,096,512	Apr 23 07:54 AM
Coric Vlad	Chief Executive Officer	Apr 22 '24	Buy	41.00	121,951	4,999,991	1,788,417	Apr 23 07:54 AM
Bailey Gregory	Director	Apr 22 '24	Buy	41.00	48,780	1,999,980	1,574,568	Apr 23 07:54 AM
Antonijevic Irina	Director	Dec 29 '23	Option Exercise	0.00	11,000	0	13,535	Dec 29 06:25 PM
Antonijevic Irina	Director	Dec 29 '23	Sale	41.79	11,000	459,662	2,535	Dec 29 06:25 PM
CHILDS JOHN W	Director	Oct 05 '23	Buy	22.00	454,545	9,999,990	3,998,952	Oct 10 07:07 PM
Coric Vlad	Chief Executive Officer	Oct 05 '23	Buy	22.00	340,908	7,499,976	833,120	Oct 10 07:17 AM
Coric Vlad	Chief Executive Officer	Oct 05 '23	Buy	22.00	113,637	2,500,014	1,657,031	Oct 10 07:17 AM
Buten Matthew	Chief Financial Officer	Oct 05 '23	Buy	22.00	22,727	499,994	189,380	Oct 06 07:38 AM
Bailey Gregory	Director	Oct 04 '23	Buy	22.57	17,817	402,094	1,525,788	Oct 06 07:37 AM
CHILDS JOHN W	Director	Aug 30 '23	Buy	18.44	50,000	922,180	1,975,118	Aug 31 08:56 AM
CHILDS JOHN W	Director	Aug 04 '23	Buy	19.78	100,000	1,978,430	1,925,118	Aug 07 07:29 AM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

CB

Chubb Limited

BHVN

Biohaven Ltd

Upgrade your FINVIZ experience